Report Detail
Global Cell Line Generation Market Growth (Status and Outlook) 2022-2028
- RnM4453981 |
- 15 June, 2022 |
- Global |
- 112 Pages |
- LPI(LP Information) |
- Medical Devices & Consumables
As the global economy mends, the 2021 growth of Cell Line Generation will have significant change from previous year. According to our (LP Information) latest study, the global Cell Line Generation market size is USD million in 2022 from USD 1641.9 million in 2021, with a change of % between 2021 and 2022. The global Cell Line Generation market size will reach USD 3265.7 million in 2028, growing at a CAGR of 10.3% over the analysis period 2022-2028.
The United States Cell Line Generation market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Cell Line Generation market, reaching US$ million by the year 2028. As for the Europe Cell Line Generation landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Cell Line Generation players cover Boehringer Ingelheim BioXcellence, Lonza, WuXi Biologics, and Thermo Fisher Scientific, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Line Generation market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Knockout Cell Lines
Overexpression Cell Lines
Inducible Expression Cell Lines
Knockdown Cell Lines
Knockin Cell Lines
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Pharmaceutical Industry
Biological Industry
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Boehringer Ingelheim BioXcellence
Lonza
WuXi Biologics
Thermo Fisher Scientific
Sartorius
Merck
Catalent
Samsung Biologics
FUJIFILM Diosynth Biotechnologies
Porton Biologics
Chempartner Pharmatech
Rentschler Biopharma
ProBioGen
AGC Biologics
OPM Biosciences
Charles River Laboratories
Mycenax Biotech
JOINN Laboratories
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Cell Line Generation Market Size 2017-2028
- 2.1.2 Cell Line Generation Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Cell Line Generation Segment by Type
- 2.2.1 Knockout Cell Lines
- 2.2.2 Overexpression Cell Lines
- 2.2.3 Inducible Expression Cell Lines
- 2.2.4 Knockdown Cell Lines
- 2.2.5 Knockin Cell Lines
- 2.2.6 Others
- 2.3 Cell Line Generation Market Size by Type
- 2.3.1 Cell Line Generation Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Cell Line Generation Market Size Market Share by Type (2017-2022)
- 2.4 Cell Line Generation Segment by Application
- 2.4.1 Pharmaceutical Industry
- 2.4.2 Biological Industry
- 2.5 Cell Line Generation Market Size by Application
- 2.5.1 Cell Line Generation Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Cell Line Generation Market Size Market Share by Application (2017-2022)
3 Cell Line Generation Market Size by Player
- 3.1 Cell Line Generation Market Size Market Share by Players
- 3.1.1 Global Cell Line Generation Revenue by Players (2020-2022)
- 3.1.2 Global Cell Line Generation Revenue Market Share by Players (2020-2022)
- 3.2 Global Cell Line Generation Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Cell Line Generation by Regions
- 4.1 Cell Line Generation Market Size by Regions (2017-2022)
- 4.2 Americas Cell Line Generation Market Size Growth (2017-2022)
- 4.3 APAC Cell Line Generation Market Size Growth (2017-2022)
- 4.4 Europe Cell Line Generation Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Cell Line Generation Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Cell Line Generation Market Size by Country (2017-2022)
- 5.2 Americas Cell Line Generation Market Size by Type (2017-2022)
- 5.3 Americas Cell Line Generation Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Cell Line Generation Market Size by Region (2017-2022)
- 6.2 APAC Cell Line Generation Market Size by Type (2017-2022)
- 6.3 APAC Cell Line Generation Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Cell Line Generation by Country (2017-2022)
- 7.2 Europe Cell Line Generation Market Size by Type (2017-2022)
- 7.3 Europe Cell Line Generation Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Cell Line Generation by Region (2017-2022)
- 8.2 Middle East & Africa Cell Line Generation Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Cell Line Generation Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Cell Line Generation Market Forecast
- 10.1 Global Cell Line Generation Forecast by Regions (2023-2028)
- 10.1.1 Global Cell Line Generation Forecast by Regions (2023-2028)
- 10.1.2 Americas Cell Line Generation Forecast
- 10.1.3 APAC Cell Line Generation Forecast
- 10.1.4 Europe Cell Line Generation Forecast
- 10.1.5 Middle East & Africa Cell Line Generation Forecast
- 10.2 Americas Cell Line Generation Forecast by Country (2023-2028)
- 10.2.1 United States Cell Line Generation Market Forecast
- 10.2.2 Canada Cell Line Generation Market Forecast
- 10.2.3 Mexico Cell Line Generation Market Forecast
- 10.2.4 Brazil Cell Line Generation Market Forecast
- 10.3 APAC Cell Line Generation Forecast by Region (2023-2028)
- 10.3.1 China Cell Line Generation Market Forecast
- 10.3.2 Japan Cell Line Generation Market Forecast
- 10.3.3 Korea Cell Line Generation Market Forecast
- 10.3.4 Southeast Asia Cell Line Generation Market Forecast
- 10.3.5 India Cell Line Generation Market Forecast
- 10.3.6 Australia Cell Line Generation Market Forecast
- 10.4 Europe Cell Line Generation Forecast by Country (2023-2028)
- 10.4.1 Germany Cell Line Generation Market Forecast
- 10.4.2 France Cell Line Generation Market Forecast
- 10.4.3 UK Cell Line Generation Market Forecast
- 10.4.4 Italy Cell Line Generation Market Forecast
- 10.4.5 Russia Cell Line Generation Market Forecast
- 10.5 Middle East & Africa Cell Line Generation Forecast by Region (2023-2028)
- 10.5.1 Egypt Cell Line Generation Market Forecast
- 10.5.2 South Africa Cell Line Generation Market Forecast
- 10.5.3 Israel Cell Line Generation Market Forecast
- 10.5.4 Turkey Cell Line Generation Market Forecast
- 10.5.5 GCC Countries Cell Line Generation Market Forecast
- 10.6 Global Cell Line Generation Forecast by Type (2023-2028)
- 10.7 Global Cell Line Generation Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Boehringer Ingelheim BioXcellence
- 11.1.1 Boehringer Ingelheim BioXcellence Company Information
- 11.1.2 Boehringer Ingelheim BioXcellence Cell Line Generation Product Offered
- 11.1.3 Boehringer Ingelheim BioXcellence Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Boehringer Ingelheim BioXcellence Main Business Overview
- 11.1.5 Boehringer Ingelheim BioXcellence Latest Developments
- 11.2 Lonza
- 11.2.1 Lonza Company Information
- 11.2.2 Lonza Cell Line Generation Product Offered
- 11.2.3 Lonza Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Lonza Main Business Overview
- 11.2.5 Lonza Latest Developments
- 11.3 WuXi Biologics
- 11.3.1 WuXi Biologics Company Information
- 11.3.2 WuXi Biologics Cell Line Generation Product Offered
- 11.3.3 WuXi Biologics Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 WuXi Biologics Main Business Overview
- 11.3.5 WuXi Biologics Latest Developments
- 11.4 Thermo Fisher Scientific
- 11.4.1 Thermo Fisher Scientific Company Information
- 11.4.2 Thermo Fisher Scientific Cell Line Generation Product Offered
- 11.4.3 Thermo Fisher Scientific Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Thermo Fisher Scientific Main Business Overview
- 11.4.5 Thermo Fisher Scientific Latest Developments
- 11.5 Sartorius
- 11.5.1 Sartorius Company Information
- 11.5.2 Sartorius Cell Line Generation Product Offered
- 11.5.3 Sartorius Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Sartorius Main Business Overview
- 11.5.5 Sartorius Latest Developments
- 11.6 Merck
- 11.6.1 Merck Company Information
- 11.6.2 Merck Cell Line Generation Product Offered
- 11.6.3 Merck Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Merck Main Business Overview
- 11.6.5 Merck Latest Developments
- 11.7 Catalent
- 11.7.1 Catalent Company Information
- 11.7.2 Catalent Cell Line Generation Product Offered
- 11.7.3 Catalent Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Catalent Main Business Overview
- 11.7.5 Catalent Latest Developments
- 11.8 Samsung Biologics
- 11.8.1 Samsung Biologics Company Information
- 11.8.2 Samsung Biologics Cell Line Generation Product Offered
- 11.8.3 Samsung Biologics Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Samsung Biologics Main Business Overview
- 11.8.5 Samsung Biologics Latest Developments
- 11.9 FUJIFILM Diosynth Biotechnologies
- 11.9.1 FUJIFILM Diosynth Biotechnologies Company Information
- 11.9.2 FUJIFILM Diosynth Biotechnologies Cell Line Generation Product Offered
- 11.9.3 FUJIFILM Diosynth Biotechnologies Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 FUJIFILM Diosynth Biotechnologies Main Business Overview
- 11.9.5 FUJIFILM Diosynth Biotechnologies Latest Developments
- 11.10 Porton Biologics
- 11.10.1 Porton Biologics Company Information
- 11.10.2 Porton Biologics Cell Line Generation Product Offered
- 11.10.3 Porton Biologics Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 Porton Biologics Main Business Overview
- 11.10.5 Porton Biologics Latest Developments
- 11.11 Chempartner Pharmatech
- 11.11.1 Chempartner Pharmatech Company Information
- 11.11.2 Chempartner Pharmatech Cell Line Generation Product Offered
- 11.11.3 Chempartner Pharmatech Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Chempartner Pharmatech Main Business Overview
- 11.11.5 Chempartner Pharmatech Latest Developments
- 11.12 Rentschler Biopharma
- 11.12.1 Rentschler Biopharma Company Information
- 11.12.2 Rentschler Biopharma Cell Line Generation Product Offered
- 11.12.3 Rentschler Biopharma Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Rentschler Biopharma Main Business Overview
- 11.12.5 Rentschler Biopharma Latest Developments
- 11.13 ProBioGen
- 11.13.1 ProBioGen Company Information
- 11.13.2 ProBioGen Cell Line Generation Product Offered
- 11.13.3 ProBioGen Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 ProBioGen Main Business Overview
- 11.13.5 ProBioGen Latest Developments
- 11.14 AGC Biologics
- 11.14.1 AGC Biologics Company Information
- 11.14.2 AGC Biologics Cell Line Generation Product Offered
- 11.14.3 AGC Biologics Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.14.4 AGC Biologics Main Business Overview
- 11.14.5 AGC Biologics Latest Developments
- 11.15 OPM Biosciences
- 11.15.1 OPM Biosciences Company Information
- 11.15.2 OPM Biosciences Cell Line Generation Product Offered
- 11.15.3 OPM Biosciences Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.15.4 OPM Biosciences Main Business Overview
- 11.15.5 OPM Biosciences Latest Developments
- 11.16 Charles River Laboratories
- 11.16.1 Charles River Laboratories Company Information
- 11.16.2 Charles River Laboratories Cell Line Generation Product Offered
- 11.16.3 Charles River Laboratories Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.16.4 Charles River Laboratories Main Business Overview
- 11.16.5 Charles River Laboratories Latest Developments
- 11.17 Mycenax Biotech
- 11.17.1 Mycenax Biotech Company Information
- 11.17.2 Mycenax Biotech Cell Line Generation Product Offered
- 11.17.3 Mycenax Biotech Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.17.4 Mycenax Biotech Main Business Overview
- 11.17.5 Mycenax Biotech Latest Developments
- 11.18 JOINN Laboratories
- 11.18.1 JOINN Laboratories Company Information
- 11.18.2 JOINN Laboratories Cell Line Generation Product Offered
- 11.18.3 JOINN Laboratories Cell Line Generation Revenue, Gross Margin and Market Share (2020-2022)
- 11.18.4 JOINN Laboratories Main Business Overview
- 11.18.5 JOINN Laboratories Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Cell Line Generation. Industry analysis & Market Report on Cell Line Generation is a syndicated market report, published as Global Cell Line Generation Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Cell Line Generation market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
